Mettler-Toledo International (NYSE:MTD) Now Covered by Citigroup

Citigroup assumed coverage on shares of Mettler-Toledo International (NYSE:MTD) in a report released on Monday, January 6th, BenzingaRatingsTable reports. The brokerage issued a neutral rating and a $800.00 price objective on the medical instruments supplier’s stock.

A number of other equities analysts have also commented on MTD. Stifel Nicolaus started coverage on Mettler-Toledo International in a research note on Thursday, November 14th. They issued a hold rating and a $790.00 price objective on the stock. ValuEngine raised Mettler-Toledo International from a sell rating to a hold rating in a research note on Thursday, November 14th. Barclays reduced their price objective on Mettler-Toledo International from $680.00 to $640.00 and set an underweight rating on the stock in a research note on Wednesday, October 9th. UBS Group dropped their target price on Mettler-Toledo International from $680.00 to $670.00 and set a sell rating for the company in a research report on Friday, November 8th. Finally, Bank of America downgraded Mettler-Toledo International from a buy rating to a neutral rating in a research report on Friday, January 3rd. Three equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $754.29.

Shares of NYSE MTD opened at $824.08 on Monday. The company has a market cap of $20.23 billion, a P/E ratio of 40.56, a P/E/G ratio of 2.51 and a beta of 1.36. The company has a quick ratio of 0.95, a current ratio of 1.34 and a debt-to-equity ratio of 2.57. Mettler-Toledo International has a 12 month low of $576.20 and a 12 month high of $873.51. The business’s 50 day moving average is $777.50 and its two-hundred day moving average is $736.69.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $5.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.71 by $0.06. The business had revenue of $753.90 million for the quarter, compared to analysts’ expectations of $751.34 million. Mettler-Toledo International had a return on equity of 105.34% and a net margin of 18.42%. Mettler-Toledo International’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the business posted $5.12 earnings per share. Sell-side analysts expect that Mettler-Toledo International will post 22.68 earnings per share for the current fiscal year.

In other news, CFO Shawn Vadala sold 100 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $711.50, for a total transaction of $71,150.00. Following the transaction, the chief financial officer now owns 5,730 shares in the company, valued at $4,076,895. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Michael Heidingsfelder sold 4,415 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $710.82, for a total value of $3,138,270.30. Following the transaction, the insider now owns 800 shares in the company, valued at approximately $568,656. The disclosure for this sale can be found here. Insiders have sold 32,799 shares of company stock valued at $23,772,284 over the last ninety days. 3.50% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the business. Ropes Wealth Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 170.6% in the 3rd quarter. Ropes Wealth Advisors LLC now owns 46 shares of the medical instruments supplier’s stock valued at $32,000 after purchasing an additional 29 shares in the last quarter. CSat Investment Advisory L.P. boosted its holdings in shares of Mettler-Toledo International by 136.0% during the 2nd quarter. CSat Investment Advisory L.P. now owns 59 shares of the medical instruments supplier’s stock valued at $50,000 after acquiring an additional 34 shares in the last quarter. Allred Capital Management LLC acquired a new stake in shares of Mettler-Toledo International during the 4th quarter valued at $72,000. CWM LLC boosted its holdings in shares of Mettler-Toledo International by 20.7% during the 3rd quarter. CWM LLC now owns 111 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 19 shares in the last quarter. Finally, Permanens Capital L.P. boosted its holdings in shares of Mettler-Toledo International by 20.0% during the 3rd quarter. Permanens Capital L.P. now owns 120 shares of the medical instruments supplier’s stock valued at $85,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 95.84% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Featured Story: What are different types of coverage ratios?

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.